reported TIM-3 overexpression in another immune cell type, called natural killer (NK) cells, which plays a critical role in eliminating malignant cells, in the peripheral blood of CLL patients. This evidence concerns the gene HAVCR2 and B-cell chronic lymphocytic leukemia.